Hong‐Lin Cheng

785 total citations
31 papers, 618 citations indexed

About

Hong‐Lin Cheng is a scholar working on Molecular Biology, Surgery and Pulmonary and Respiratory Medicine. According to data from OpenAlex, Hong‐Lin Cheng has authored 31 papers receiving a total of 618 indexed citations (citations by other indexed papers that have themselves been cited), including 11 papers in Molecular Biology, 10 papers in Surgery and 9 papers in Pulmonary and Respiratory Medicine. Recurrent topics in Hong‐Lin Cheng's work include Bladder and Urothelial Cancer Treatments (5 papers), Prostate Cancer Treatment and Research (4 papers) and Kidney Stones and Urolithiasis Treatments (3 papers). Hong‐Lin Cheng is often cited by papers focused on Bladder and Urothelial Cancer Treatments (5 papers), Prostate Cancer Treatment and Research (4 papers) and Kidney Stones and Urolithiasis Treatments (3 papers). Hong‐Lin Cheng collaborates with scholars based in Taiwan, China and United States. Hong‐Lin Cheng's co-authors include Tzong‐Shin Tzai, Guillermo E. Taccioli, A. J. Varghese, Frederick W. Alt, G. F. Whitmore, Nan‐Haw Chow, Yat‐Ching Tong, S.T.H. Chan, Chin‐Wei Kuo and Wei‐Yang Chou and has published in prestigious journals such as Journal of Biological Chemistry, Journal of Clinical Oncology and SHILAP Revista de lepidopterología.

In The Last Decade

Hong‐Lin Cheng

29 papers receiving 607 citations

Peers

Hong‐Lin Cheng
Xiaohua Zhang China
Min Hyung Jung South Korea
Di Sun China
Mauro Seveso Italy
Stephen D. Lyons Australia
Brian J. Simmons United States
Ruiqin Han China
Haifeng Song China
Lihui Wei China
Francesca Pirini Italy
Xiaohua Zhang China
Hong‐Lin Cheng
Citations per year, relative to Hong‐Lin Cheng Hong‐Lin Cheng (= 1×) peers Xiaohua Zhang

Countries citing papers authored by Hong‐Lin Cheng

Since Specialization
Citations

This map shows the geographic impact of Hong‐Lin Cheng's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Hong‐Lin Cheng with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Hong‐Lin Cheng more than expected).

Fields of papers citing papers by Hong‐Lin Cheng

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Hong‐Lin Cheng. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Hong‐Lin Cheng. The network helps show where Hong‐Lin Cheng may publish in the future.

Co-authorship network of co-authors of Hong‐Lin Cheng

This figure shows the co-authorship network connecting the top 25 collaborators of Hong‐Lin Cheng. A scholar is included among the top collaborators of Hong‐Lin Cheng based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Hong‐Lin Cheng. Hong‐Lin Cheng is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
2.
3.
Jiang, Yu, et al.. (2022). The DeltaN p63 Promotes EMT and Metastasis in Bladder Cancer by the PTEN/AKT Signalling Pathway. Evidence-based Complementary and Alternative Medicine. 2022. 1–9. 1 indexed citations
4.
Tsai, Yuh‐Shyan, et al.. (2022). Dynamic changes of quality of life in muscle-invasive bladder cancer survivors. BMC Urology. 22(1). 126–126. 5 indexed citations
5.
Zhao, Xin, Daixing Hu, Jia Li, et al.. (2020). Database Mining of Genes of Prognostic Value for the Prostate Adenocarcinoma Microenvironment Using the Cancer Gene Atlas. BioMed Research International. 2020(1). 5019793–5019793. 28 indexed citations
6.
7.
Cheng, Hong‐Lin, Xin Li, Chuanlin Wang, et al.. (2018). Inhibition of tankyrase by a novel small molecule significantly attenuates prostate cancer cell proliferation. Cancer Letters. 443. 80–90. 34 indexed citations
8.
Cheng, Hong‐Lin, Yicheng Zhou, Yushan Zhu, et al.. (2013). Myostatin induces mitochondrial metabolic alteration and typical apoptosis in cancer cells. Cell Death and Disease. 4(2). e494–e494. 32 indexed citations
9.
Cheng, Hong‐Lin, B. R. Ou, Nan‐Haw Chow, et al.. (2011). Urinary CD14 as a potential biomarker for benign prostatic hyperplasia – discovery by combining MALDI‐TOF‐based biostatistics and ESI‐MS/MS‐based stable‐isotope labeling. PROTEOMICS - CLINICAL APPLICATIONS. 5(3-4). 121–132. 12 indexed citations
10.
Yu, Hong‐Jeng, Alex Tong‐Long Lin, Stephen Shei‐Dei Yang, et al.. (2011). Non‐inferiority of silodosin to tamsulosin in treating patients with lower urinary tract symptoms (LUTS) associated with benign prostatic hyperplasia (BPH). British Journal of Urology. 108(11). 1843–1848. 55 indexed citations
11.
Cheng, Hong‐Lin, Chunli Luo, Xiaohou Wu, et al.. (2011). shRNA Targeting PLCε Inhibits Bladder Cancer Cell Growth In Vitro and In Vivo. Urology. 78(2). 474.e7–474.e11. 32 indexed citations
12.
Chen, Yu‐Chi, et al.. (2007). Caecomyces sympodialis sp. nov., a new rumen fungus isolated from Bos indicus. Mycologia. 99(1). 125–130. 31 indexed citations
13.
Chiou, Yuan‐Yow, Chi‐Chang Shieh, & Hong‐Lin Cheng. (2006). In situ expression of T‐helper type 2 immunoregulatory response in myofibroblast of a pediatric bladder inflammatory pseudotumor. Pathology International. 56(3). 154–157. 1 indexed citations
14.
Chou, Wei‐Yang, Chin‐Wei Kuo, Hong‐Lin Cheng, et al.. (2006). Epitaxial pentacene films grown on the surface of ion-beam-processed gate dielectric layer. Journal of Applied Physics. 99(11). 6 indexed citations
15.
Cheng, Hong‐Lin, et al.. (2005). Inflammatory pseudotumor of the bladder: a rare cause of hematuria with impending shock in a child.. PubMed. 45(6). 350–3. 3 indexed citations
16.
Cheng, Hong‐Lin, et al.. (2002). Spontaneous pyeloduodenal fistula: an unusual presentation in advanced renal transitional cell carcinoma. Urology. 60(2). 345–345. 5 indexed citations
17.
Chow, Nan‐Haw, et al.. (2000). The clinical value of p21WAF1/CIP1 expression in superficial bladder cancer.. PubMed. 20(2B). 1173–6. 13 indexed citations
18.
Lin, Yung-Ming, et al.. (1997). Fournier's Gangrene: Experience with 21 Patients in NCKUH. 8(1). 38–42. 1 indexed citations
19.
Liu, Hsiao‐Sheng, et al.. (1996). IDIOPATHIC INFECTED HYDROCELE IN INFANTS: A CASE REPORT AND REVIEW. The Pediatric Infectious Disease Journal. 15(6). 545–546. 6 indexed citations
20.
Chow, Nan‐Haw, et al.. (1994). Urinary Cytodiagnosis: Can It Have a Different Prognostic Implication than a Diagnostic Test?. Urologia Internationalis. 53(1). 18–23. 13 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Xiaohua Zhang Breakdown of academic impact, for papers by Min Hyung Jung Breakdown of academic impact, for papers by Di Sun Breakdown of academic impact, for papers by Mauro Seveso Breakdown of academic impact, for papers by Stephen D. Lyons Breakdown of academic impact, for papers by Brian J. Simmons Breakdown of academic impact, for papers by Ruiqin Han Breakdown of academic impact, for papers by Haifeng Song Breakdown of academic impact, for papers by Lihui Wei Breakdown of academic impact, for papers by Francesca Pirini
Rankless by CCL
2026